万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/1932846x
3、投稿网址：
http://mc.manuscriptcentral.com/neuro-wiley
4、官网邮箱：dneuadmin@wiley.com（编辑部）
dneuprod@wiley.com
5、期刊刊期：月刊，一年出版十二期。
2021年5月6日星期四
投稿须知【官网信息】
Author Guidelines
1. SUBMISSION
Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Developmental Neurobiology will consider submissions that have previously been made available online, either on a preprint server like arXiv, bioRxiv, or PeerJ PrePrints, or on the authors’ own website. However, any such submissions must not have been published in a scientific journal, book or other venue that could be considered formal publication. Authors must inform the editorial office at submission if their paper has been made available as a preprint.
Authors of accepted papers that were made available as preprints must be able to assign copyright to Developmental Neurobiology, or agree to the terms of the Wiley Open Access agreement and pay the associated fee
Given that the measurable impact of the article is diminished when citations are split between the preprint and the published article, authors are required to:
Update the entry on the preprint server so that it links to and cites the DOI for the published version
Cite only the published article themselves
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online via the journal's ScholarOne site: mc.manuscriptcentral.com/neuro-wiley. For more details on how to use ScholarOne, visit www.wileyauthors.com/scholarone.
The submission system will prompt authors to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
For help with submissions, please contact the Editorial Office: dneuadmin@wiley.com. When necessary, the Editorial Office staff may refer questions to the Editors-in-Chief or Senior Editors.
2. AIMS AND SCOPE
Developmental Neurobiology publishes original research articles and critical review papers on all aspects of nervous system development and aging, including plasticity and the ontogeny of behavior, and regeneration and repair as well as changes brought about by disease. The general aim of the journal is to be the forum of choice for the broad presentation and discussion of the mechanisms underlying the dynamic nature of the structural and functional properties of the nervous system.
The journal welcomes reports of mechanistic studies that use the whole range of genetic, epigenetic, molecular, cellular, physiological, anatomical or behavioral tools to examine the differentiation and maturation of neural stem or primary cells, in vitro and in vivo, across the varied lifespans of invertebrates, vertebrates and humans, both in normal development and aging, and in disease. Topics of particular current interest, beside basic molecular and cellular mechanisms of neural development and neuroevolution, include neuroinflammation and neuroimmune responses, neurodevelopmental disorders, comparative studies of diseases of the nervous system, and the use of stem cells in nervous system repair, among others.
The journal also publishes Special Issues on topics of significant current interest, including those devoted to specific vertebrate or invertebrate groups that are advantageous for addressing neural dynamics. A complete list of forthcoming and past Special Issues can be found elsewhere. The Editors welcome suggestions of possible topics for future Special Issues, and interested readers should contact the Editorial Office with their proposal for the Editors’ consideration.
The Editors also welcome pre-submission inquiries of the journal’s interest in publishing any original research reports, as well as Review articles covering relevant active research areas. Interested readers should contact the Editorial Office with an article outline or draft abstract for the Editors’ consideration.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Developmental Neurobiology publishes the following contribution types:
Research Articles
Review Articles
Technical Reports
Manuscripts should be prepared according to the descriptions below. Submissions that do not conform to the relevant descriptions below may be returned to the author. Note, all contributions require an Abstract and Keywords.
1) Research Articles
Research Articles are full-length reports of quality current research within any area covered by the journal (see Section 2. Aims and Scope). Such contributions report new research findings or conceptual analyses that make a significant contribution to the scientific knowledge. The manuscript should contain a 250-word abstract, and the main text should contain the following sections in this order: Introduction, Materials and Methods, Results, Discussion (i.e., follow the IMRaD guidelines). These sections should be numbered and appropriately cross-referenced within the text.
Authors are encouraged to make use of the “Resources for Writing Your Paper” section of www.wileyauthors.com/prepare when preparing their manuscript for submission; resources include blog posts on writing an effective abstract and the importance of a well-written introduction.
2) Review Articles
Review Articles are typically written by leading experts in a field within the journal’s scope. These focused, topical overview papers help specialists to remain up to date with the information published in their subject while being informative for the non-specialist. As such, a Review Article should focus on recent developments in a given field, describe current trends and as applicable methodologies, and provide a critical opinion intended to a broad readership. Authors should avoid concentrating solely or preferentially on their own work. Such reviews are typically about 3000 words, not including a 250-word abstract, references, figures, and tables. While there is no specific limit to the number of references, the list of cited material should be kept concise, reflecting the current state of the field.
4. PREPARING THE SUBMISSION
Parts of the Manuscript
The submission should be uploaded in separate files: 1) manuscript main text file(inc. tables and figure captions); 2) individual figure files; 3) Supporting information file(s); 4) Additional files.
1) Main Text File
The text file should be presented in the following order:
A short informative containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
A short running title of less than 40 characters;
The full names of the authors;
The author's institutional affiliations where the work was conducted, with a footnote for an author’s present address if different from where the work was conducted;
Acknowledgments;
Abstract and keywords;
Main text;
References;
Tables (each table complete with title and footnotes);
Figure legends;
Title
The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).
Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
In accordance with Wiley's Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics' guidance, Developmental Neurobiology will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors - including those to be added or removed - must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal's editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author's name; the relevant policy for that can be found in Wiley's Best Practice Guidelines under "Author name changes after publication."]
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a Conflict of Interest statement during the submission process. For details on what to include in this section, see the Conflict of Interest section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Abstract
The Abstract is a single paragraph that states the principal results and conclusions in no more than 250 words. All contribution types published in the journal require an Abstract. The Abstract should include relevant keywords (see below) to drive search engine optimization (SEO).
Keywords
Please provide five to seven keywords. To drive SEO, keywords should be chosen carefully and used appropriately throughout the manuscript (see Wiley's best practice SEO tips).
Main Text
Manuscripts reporting original research should follow the IMRaD guidelines (Introduction, Methods, Results, and Discussion), which are recommended by the International Committee of Medical Journal Editors (ICMJE) (J. Pharmacol. Pharmacother. 2010, 1, 42–58).
Language: Authors for whom English is a second language are encouraged to seek assistance from a native English speaker prior to submission to optimize expression; alternatively, authors can employ a professional service such as the Wiley Editing Services. All authors should take care to polish their draft manuscript to address any typographical errors prior to submission.
Spelling: The journal uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word or phrase in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only. The title should NOT include any abbreviations unless widely understood. Abbreviations may be used in the Abstract, but must be defined in the first instance.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.
Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8 mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
Species Names: Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.
Genetic Nomenclature: Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.
References
References should be prepared according to the Publication Manual of the American Psychological Association (6th edition). This means in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper. Please note that for journal articles, issue numbers are not included unless each issue in the volume begins with page 1, and a DOI should be provided for all references where available.
For more information about APA referencing style, please refer to the Frequently Asked Questions About APA Style.
Reference examples follow:
Journal article
Beers, S. R. , & De Bellis, M. D. (2002). Neuropsychological function in children with maltreatment-related posttraumatic stress disorder. The American Journal of Psychiatry, 159, 483–486. doi: 10.1176/appi.ajp.159.3.483
Book
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who are visually impaired or blind: Infancy through high school (2nd ed.). Austin, TX: Pro-ed.
Internet Document
Norton, R. (2006, November 4). How to train a cat to operate a light switch [Video file]. Retrieved from https://www.youtube.com/watch?v=b7SZDlpidQs
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied in an editable format (i.e., created in Microsoft Word and presented in the manuscript file), not pasted as images. Each Table should have a concise title, and concise but comprehensive footnotes. The table, including the title and footnotes, must be understandable without reference to the text. All abbreviations must be defined. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the column heading(s) or where appropriate.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Inclusion of Copyrighted Material
Authors wishing to use previously published material such as figures must obtain written permission from the original publisher (i.e., the copyright holder), and it should be clear in the caption that the figure is reproduced or adapted from elsewhere.
Authors wishing to cite unpublished results that are not their own or personal communications in the manuscript must obtain a signed letter of permission from cited persons. All permissions documentation must be provided at submission.
2) Figure Files
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Figures submitted in color, if the manuscript is accepted for publication, may be reproduced in color online free of charge. Please note, however, that it is preferable that line figures (e.g., graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white. If an author would prefer to have figures printed in colour in hard copies of the journal, a fee will be charged by the Publisher.
3) Supporting Information
Supporting Information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on Supporting Information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
4) Additional Files
Additional files are materials relevant to the evaluation of a submission but not intended for publication, should the manuscript be accepted. Examples include in press articles cited in the manuscript but not yet available; related manuscripts under consideration that have a bearing on the current submission; confidential datasets where access is required for peer-review purposes.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to the journal’a readership and fields represented by the journal. All submissions to Developmental Neurobiology are subject to evaluation. Papers will only be sent to review if the Editor determines that the paper meets the appropriate quality and relevance requirements. Papers that do not conform to the general criteria for publication in Developmental Neurobiology will be returned to the author immediately without detailed review in order to avoid unnecessary delay in submission elsewhere. In some instances, a referral to another Wiley Neuroscience journal may be offered (see elsewhere).
Except where otherwise stated, manuscripts are single-blind peer reviewed. Wiley's policy on the confidentiality of the review process is available here: www.wileypeerreview.com/reviewpolicy.
Data Sharing and Data Accessibility
Please review Wiley’s policy here. Developmental Neurobiology expects but does not require data sharing.
All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. Developmental Neurobiology recognizes the many benefits of archiving research data. Developmental Neurobiology expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles.
Developmental Neurobiology notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.
Conflicts of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication, provided the conflict is disclosed. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: www.crossref.org/services/funder-registry.
Authorship
The list of authors should accurately represent who contributed to the work and how. Qualification for authorship is based on the following criteria. All listed authors should:
1) Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2) Been involved in drafting the manuscript or revising it critically for important intellectual content;
3) Have given final approval of the version to be published;
4) Have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
5) Have agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support).
Prior to submitting the manuscript, all authors should agree on the order in which their names will be listed in the manuscript.
Additional Authorship Options
Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. If the submitting author is not already registered with ORCiD, they can do so here: orcid.org/register; this takes around 2 minutes to complete. For more information, visit www.wileyauthors.com/orcid.
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note, this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here: www.wileyauthors.com/ethics. Wiley’s Publication Ethics Guidelines can be found here.
6. EDITORIAL POLICIES ON REPORTING OF SCIENTIFIC RESEARCH
Accurate and complete reporting of scientific research results enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to the relevant community-led research reporting standards, such as those listed here:
Consolidated Standards of Reporting Trials (CONSORT)
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
PRISMA Protocols (PRISMA-P)
TRIPOD: Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis
FORCE11: Recommended reporting guidelines for life science resources (see also the Resource Identification Initiative)
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines
Guidance for the Description of Animal Research in Scientific Publications from the US National Research Council's Institute for Laboratory Animal Research
The Gold Standard Publication Checklist from Hooijmans et al. (ATLA (2010) 38: 167–182)
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI)
Biosharing Standards
Resource Identification Initiative
The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library , provides unique identifiers for antibodies, model organisms, cell lines, and tools such as software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can therefore be used to search for all papers in which a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
……
